Upgrade to CSIRO Protein Production Platform

Biologics are the fastest-growing 'pillar' of the biopharmaceutical industry, largely due to their specificity and tolerability (resulting in a generally faster regulatory approval process) and the success of key blockbuster products, particularly in the antibody space.

This project is aiming to upgrade the CSIRO protein production platform at Clayton to human Good Manufacturing Process (GMP) capability for pilot-scale (less than 200L) for a variety of expression systems (mammalian/yeast/ bacterial) as well as scale-up of cells.

The proposal extends beyond a facility upgrade to encompass a CSIRO and Monash collaboration to support training in quality systems, GMP, analytics and bioprocess development. To achieve this the facilities will be developed with teaching requirements as part of the plan.